Antineutrophil cytoplasm antibody-positive pulmonary-renal syndrome in a patient with diffuse cutaneous systemic sclerosis

por Tonneijck, Lennart, Tanna, Anisha, Pusey, Charles D
Publicado 2013

Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males

por Smits, Mark M., Muskiet, Marcel H. A., Tonneijck, Lennart, Hoekstra, Trynke, Kramer, Mark H. H., Diamant, Michaela, van Raalte, Daniël H.
Publicado en Br J Clin Pharmacol (2016)

SGLT2 Inhibition in the Diabetic Kidney—From Mechanisms to Clinical Outcome

por van Bommel, Erik J.M., Muskiet, Marcel H.A., Tonneijck, Lennart, Kramer, Mark H.H., Nieuwdorp, Max, van Raalte, Daniel H.
Publicado en Clin J Am Soc Nephrol (2017)

Plasma uric acid and renal haemodynamics in type 2 diabetes patients

por Suijk, Danii LS, Smits, Mark M, Muskiet, Marcel HA, Tonneijck, Lennart, Kramer, Mark HH, Joles, Jaap A, van Raalte, Daniël H
Publicado en Nephrology (Carlton) (2019)

Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis...

por Kraaijenhof, Jordan, Muskiet, Marcel H. A., Tonneijck, Lennart, Ouwens, D. Margriet, Kramer, Mark H. H., van Raalte, Daniël H., Smits, Mark M.
Publicado en Diabetes Obes Metab (2020)

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment

por Tonneijck, Lennart, Muskiet, Marcel H.A., Smits, Mark M., van Bommel, Erik J., Heerspink, Hiddo J.L., van Raalte, Daniël H., Joles, Jaap A.
Publicado en J Am Soc Nephrol (2017)

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

por Spit, Karlinde A., Muskiet, Marcel H. A., Tonneijck, Lennart, Smits, Mark M., Kramer, Mark H. H., Joles, Jaap A., de Boer, Anneloes, van Raalte, Daniel H.
Publicado en MAGMA (2019)

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in...

por Smits, Mark M, Tonneijck, Lennart, Muskiet, Marcel H A, Hoekstra, Trynke, Kramer, Mark H H, Pieters, Indra C, Cahen, Djuna L, Diamant, Michaela, van Raalte, Daniël H
Publicado en BMJ Open (2015)

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and its kidney clearance: post-hoc analyses of four clinical trials

por Tonneijck, Lennart, Muskiet, Marcel H.A., Smits, Mark M., Bjornstad, Petter, Kramer, Mark H.H., Diamant, Michaela, Hoorn, Ewout J., Joles, Jaap A., van Raalte, Daniël H.
Publicado en Diabetes Obes Metab (2018)

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

por Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H. A., Hoekstra, Trynke, Kramer, Mark H. H., Danser, A. H. Jan, Diamant, Michaela, Joles, Jaap A., van Raalte, Daniël H.
Publicado en Diabetologia (2016)

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients

por Smits, Mark M., Tonneijck, Lennart, Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Diamant, Michaela, Nieuwdorp, Max, Groen, Albert K., Cahen, Djuna L., van Raalte, Daniël H.
Publicado en Diabetes Obes Metab (2016)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placeb...

por Tonneijck, Lennart, Smits, Mark M., Muskiet, Marcel H.A., Hoekstra, Trynke, Kramer, Mark H.H., Danser, A.H. Jan, ter Wee, Piet M., Diamant, Michaela, Joles, Jaap A., van Raalte, Daniel H.
Publicado en Diabetes Care (2019)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial

por Smits, Mark M., Tonneijck, Lennart, Muskiet, Marcel H. A., Kramer, Mark H. H., Pouwels, Petra J. W., Pieters-van den Bos, Indra C., Hoekstra, Trynke, Diamant, Michaela, van Raalte, Daniël H., Cahen, Djuna L.
Publicado en Diabetologia (2016)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

por Sivalingam, Suvanjaa, Larsen, Emil List, van Raalte, Daniel H., Muskiet, Marcel H. A., Smits, Mark M., Tonneijck, Lennart, Joles, Jaap A., von Scholten, Bernt Johan, Zobel, Emilie Hein, Persson, Frederik, Henriksen, Trine, Diaz, Lars Jorge, Hansen, Tine W., Poulsen, Henrik Enghusen, Rossing, Peter
Publicado en Sci Rep (2021)